Agios Pharmaceuticals, Inc.
AGIO
$34.41
-$1.09-3.07%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 893.38M | 893.71M | 1.00B | 569.89M | 597.99M |
| Total Receivables | 3.34M | 4.11M | 3.12M | 3.76M | 3.45M |
| Inventory | 29.61M | 27.62M | 26.43M | 23.94M | 23.07M |
| Prepaid Expenses | 42.29M | 40.17M | 39.89M | 34.54M | 39.11M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 968.62M | 965.60M | 1.07B | 632.13M | 663.63M |
|
|
|||||
| Total Current Assets | 968.62M | 965.60M | 1.07B | 632.13M | 663.63M |
| Net Property, Plant & Equipment | 50.93M | 54.55M | 57.66M | 61.48M | 65.73M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 4.72M | 4.72M | 4.06M | 4.06M | 4.06M |
| Total Assets | 1.56B | 1.66B | 1.79B | 773.06M | 849.71M |
|
|
|||||
| Total Accounts Payable | 13.73M | 16.64M | 17.14M | 10.04M | 11.16M |
| Total Accrued Expenses | 20.76M | 46.86M | 33.31M | 36.74M | 25.13M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 17.20M | 16.78M | 16.32M | 15.86M | 15.41M |
| Total Finance Division Other Current Liabilities | 683.00K | 871.00K | 52.68M | -- | -- |
| Total Other Current Liabilities | 683.00K | 871.00K | 52.68M | -- | -- |
| Total Current Liabilities | 52.37M | 81.16M | 119.45M | 62.64M | 51.69M |
|
|
|||||
| Total Current Liabilities | 52.37M | 81.16M | 119.45M | 62.64M | 51.69M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 35.74M | 40.21M | 44.52M | 48.76M | 52.94M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 880.00K | 880.00K | 1.16M | 1.16M | 1.16M |
| Total Liabilities | 88.99M | 122.24M | 165.12M | 112.55M | 105.79M |
|
|
|||||
| Common Stock & APIC | 2.51B | 2.49B | 2.48B | 2.46B | 2.45B |
| Retained Earnings | -238.21M | -148.92M | -52.40M | -1.00B | -904.20M |
| Treasury Stock & Other | -802.12M | -804.00M | -799.07M | -803.53M | -803.57M |
| Total Common Equity | 1.47B | 1.54B | 1.63B | 660.51M | 743.92M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.47B | 1.54B | 1.63B | 660.51M | 743.92M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.47B | 1.54B | 1.63B | 660.51M | 743.92M |
|
|
|||||